Cargando…
Amb a 1 isoforms: Unequal siblings with distinct immunological features
BACKGROUND: Ragweed pollen represents a major allergy risk factor. Ragweed extracts contain five different isoforms of the major allergen Amb a 1. However, the immunological characteristics of Amb a 1 isoforms are not fully investigated. Here, we compared the physicochemical and immunological proper...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700413/ https://www.ncbi.nlm.nih.gov/pubmed/28464293 http://dx.doi.org/10.1111/all.13196 |
_version_ | 1783281115853750272 |
---|---|
author | Wolf, M. Twaroch, T. E. Huber, S. Reithofer, M. Steiner, M. Aglas, L. Hauser, M. Aloisi, I. Asam, C. Hofer, H. Parigiani, M. A. Ebner, C. Bohle, B. Briza, P. Neubauer, A. Stolz, F. Jahn‐Schmid, B. Wallner, M. Ferreira, F. |
author_facet | Wolf, M. Twaroch, T. E. Huber, S. Reithofer, M. Steiner, M. Aglas, L. Hauser, M. Aloisi, I. Asam, C. Hofer, H. Parigiani, M. A. Ebner, C. Bohle, B. Briza, P. Neubauer, A. Stolz, F. Jahn‐Schmid, B. Wallner, M. Ferreira, F. |
author_sort | Wolf, M. |
collection | PubMed |
description | BACKGROUND: Ragweed pollen represents a major allergy risk factor. Ragweed extracts contain five different isoforms of the major allergen Amb a 1. However, the immunological characteristics of Amb a 1 isoforms are not fully investigated. Here, we compared the physicochemical and immunological properties of three most important Amb a 1 isoforms. METHODS: After purification, the isoforms were physicochemically characterized, tested for antibody binding and induction of human T‐cell proliferative responses. Their immunological properties were further evaluated in vitro and in vivo in a mouse model. RESULTS: Amb a 1 isoforms exhibited distinct patterns of IgE binding and immunogenicity. Compared to Amb a 1.02 or 03 isoforms, Amb a 1.01 showed higher IgE‐binding activity. Isoforms 01 and 03 were the most potent stimulators of patients’ T cells. In a mouse model of immunization, Amb a 1.01 induced higher levels of IgG and IgE antibodies when compared to isoforms 02 and 03. Interestingly, ragweed‐sensitized patients also displayed an IgG response to Amb a 1 isoforms. However, unlike therapy‐induced antibodies, sensitization‐induced IgG did not show IgE‐blocking activity. CONCLUSION: The present study showed that naturally occurring isoforms of Amb a 1 possess different immunogenic and sensitizing properties. These findings should be considered when selecting sequences for molecule‐based diagnosis and therapy for ragweed allergy. Due to its high IgE‐binding activity, isoform Amb a 1.01 should be included in diagnostic tests. In contrast, due to their limited B‐ and T‐cell cross‐reactivity patterns, a combination of different isoforms might be a more attractive strategy for ragweed immunotherapy. |
format | Online Article Text |
id | pubmed-5700413 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-57004132017-12-01 Amb a 1 isoforms: Unequal siblings with distinct immunological features Wolf, M. Twaroch, T. E. Huber, S. Reithofer, M. Steiner, M. Aglas, L. Hauser, M. Aloisi, I. Asam, C. Hofer, H. Parigiani, M. A. Ebner, C. Bohle, B. Briza, P. Neubauer, A. Stolz, F. Jahn‐Schmid, B. Wallner, M. Ferreira, F. Allergy ORIGINAL ARTICLES BACKGROUND: Ragweed pollen represents a major allergy risk factor. Ragweed extracts contain five different isoforms of the major allergen Amb a 1. However, the immunological characteristics of Amb a 1 isoforms are not fully investigated. Here, we compared the physicochemical and immunological properties of three most important Amb a 1 isoforms. METHODS: After purification, the isoforms were physicochemically characterized, tested for antibody binding and induction of human T‐cell proliferative responses. Their immunological properties were further evaluated in vitro and in vivo in a mouse model. RESULTS: Amb a 1 isoforms exhibited distinct patterns of IgE binding and immunogenicity. Compared to Amb a 1.02 or 03 isoforms, Amb a 1.01 showed higher IgE‐binding activity. Isoforms 01 and 03 were the most potent stimulators of patients’ T cells. In a mouse model of immunization, Amb a 1.01 induced higher levels of IgG and IgE antibodies when compared to isoforms 02 and 03. Interestingly, ragweed‐sensitized patients also displayed an IgG response to Amb a 1 isoforms. However, unlike therapy‐induced antibodies, sensitization‐induced IgG did not show IgE‐blocking activity. CONCLUSION: The present study showed that naturally occurring isoforms of Amb a 1 possess different immunogenic and sensitizing properties. These findings should be considered when selecting sequences for molecule‐based diagnosis and therapy for ragweed allergy. Due to its high IgE‐binding activity, isoform Amb a 1.01 should be included in diagnostic tests. In contrast, due to their limited B‐ and T‐cell cross‐reactivity patterns, a combination of different isoforms might be a more attractive strategy for ragweed immunotherapy. John Wiley and Sons Inc. 2017-06-14 2017-12 /pmc/articles/PMC5700413/ /pubmed/28464293 http://dx.doi.org/10.1111/all.13196 Text en © 2017 The Authors. Allergy Published by John Wiley & Sons Ltd This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | ORIGINAL ARTICLES Wolf, M. Twaroch, T. E. Huber, S. Reithofer, M. Steiner, M. Aglas, L. Hauser, M. Aloisi, I. Asam, C. Hofer, H. Parigiani, M. A. Ebner, C. Bohle, B. Briza, P. Neubauer, A. Stolz, F. Jahn‐Schmid, B. Wallner, M. Ferreira, F. Amb a 1 isoforms: Unequal siblings with distinct immunological features |
title | Amb a 1 isoforms: Unequal siblings with distinct immunological features |
title_full | Amb a 1 isoforms: Unequal siblings with distinct immunological features |
title_fullStr | Amb a 1 isoforms: Unequal siblings with distinct immunological features |
title_full_unstemmed | Amb a 1 isoforms: Unequal siblings with distinct immunological features |
title_short | Amb a 1 isoforms: Unequal siblings with distinct immunological features |
title_sort | amb a 1 isoforms: unequal siblings with distinct immunological features |
topic | ORIGINAL ARTICLES |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700413/ https://www.ncbi.nlm.nih.gov/pubmed/28464293 http://dx.doi.org/10.1111/all.13196 |
work_keys_str_mv | AT wolfm amba1isoformsunequalsiblingswithdistinctimmunologicalfeatures AT twarochte amba1isoformsunequalsiblingswithdistinctimmunologicalfeatures AT hubers amba1isoformsunequalsiblingswithdistinctimmunologicalfeatures AT reithoferm amba1isoformsunequalsiblingswithdistinctimmunologicalfeatures AT steinerm amba1isoformsunequalsiblingswithdistinctimmunologicalfeatures AT aglasl amba1isoformsunequalsiblingswithdistinctimmunologicalfeatures AT hauserm amba1isoformsunequalsiblingswithdistinctimmunologicalfeatures AT aloisii amba1isoformsunequalsiblingswithdistinctimmunologicalfeatures AT asamc amba1isoformsunequalsiblingswithdistinctimmunologicalfeatures AT hoferh amba1isoformsunequalsiblingswithdistinctimmunologicalfeatures AT parigianima amba1isoformsunequalsiblingswithdistinctimmunologicalfeatures AT ebnerc amba1isoformsunequalsiblingswithdistinctimmunologicalfeatures AT bohleb amba1isoformsunequalsiblingswithdistinctimmunologicalfeatures AT brizap amba1isoformsunequalsiblingswithdistinctimmunologicalfeatures AT neubauera amba1isoformsunequalsiblingswithdistinctimmunologicalfeatures AT stolzf amba1isoformsunequalsiblingswithdistinctimmunologicalfeatures AT jahnschmidb amba1isoformsunequalsiblingswithdistinctimmunologicalfeatures AT wallnerm amba1isoformsunequalsiblingswithdistinctimmunologicalfeatures AT ferreiraf amba1isoformsunequalsiblingswithdistinctimmunologicalfeatures |